Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Ipilimumab × 90 days × Clear all

Sponsor

Conditions

Melanoma 27 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 15 Neoplasm Metastasis 9 Skin Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Lung Neoplasms 5 Kidney Neoplasms 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Urogenital Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Penile Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Glioblastoma 3 Uveal Melanoma 2 Ureteral Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroendocrine Tumors 2 Myelodysplastic Syndromes 2

Interventions

Paclitaxel 5 Bevacizumab 5 Carboplatin 4 mirvetuximab soravtansine 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Hyperthermic Intraperitoneal Chemotherapy 2 trastuzumab deruxtecan 1 rucaparib 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 niraparib 1 isoquercitrin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 Topotecan 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Pharmaceutical Preparations 1 Nutrition Assessment 1 Nivolumab 1 Neoadjuvant Therapy 1 Injections 1 Immunotherapy, Adoptive 1 Glucose 1 GEN-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡